Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105142 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chang-Yu Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan. Hauptthemen laut MEDLINE: Chondrosarcoma, Lymphangiogenesis, MicroRNAs, Nicotinamide Phosphoribosyltransferase. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taiwan's Ministry of Science and Technology, China Medical University, China Medical University Hospital.
Abstract (Originalsprache)
Chondrosarcoma is a malignant bone tumor that arises from abnormalities in cartilaginous tissue and is associated with lung metastases. Lymphangiogenesis plays an essential role in cancer metastasis. Visfatin is an adipokine reported to enhance tumor metastasis, but its relationship with VEGF-D generation and lymphangiogenesis in chondrosarcoma remains undetermined. Our results from clinical samples reveal that VEGF-D levels are markedly higher in chondrosarcoma patients than in normal individuals. Visfatin stimulation promotes VEGF-D-dependent lymphatic endothelial cell lymphangiogenesis. We also found that visfatin induces VEGF-D production by activating HIF-1α and reducing miR-2277-3p generation through the Raf/MEK/ERK signaling cascade. Importantly, visfatin controls chondrosarcoma-related lymphangiogenesis in vivo. Therefore, visfatin is a promising target in the treatment of chondrosarcoma lymphangiogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Science, China Medical University, Taichung 40402, Taiwan.
- Minimally Invasive Spine and Joint Center, Buddhist Tzu Chi General Hospital Taichung Branch, Taichung 42721, Taiwan.
- Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung 41354, Taiwan.
- Translational Medicine Center, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 11104, Taiwan.
- Institute of Biomedical Sciences, Mackay Medical College, New Taipei City 25245, Taiwan.
- Department of Medicine, Mackay Medical College, New Taipei City 25245, Taiwan.
ORCID-Profile: Shih-Wei Wang, Chun-Hao Tsai, Yuan-Shun Lo, Chih-Hsin Tang
Förderung
- Taiwan's Ministry of Science and Technology
- China Medical University
- China Medical University Hospital
- Taiwan’s Ministry of Science and Technology
Zitieren
APA
Song, C. Y., Hsieh, S. L., Yang, S. Y., Lin, C. Y., Wang, S. W., Tsai, C. H., Lo, Y. S., Fong, Y. C., & Tang, C. H. (2024). Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105142
Vancouver
Song CY, Hsieh SL, Yang SY, Lin CY, Wang SW, Tsai CH, et al. Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105142
BibTeX
@article{Song2024,
author = {Song, Chang-Yu and Hsieh, Shang-Lin and Yang, Shang-Yu and Lin, Chih-Yang and Wang, Shih-Wei and Tsai, Chun-Hao and Lo, Yuan-Shun and Fong, Yi-Chin and Tang, Chih-Hsin},
title = {Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105142}
}
EUVIMED